Valganciclovir: A Review of its Use in the Management of CMV Infection and Disease in Immunocompromised Patients

Author： Cvetković Risto S.   Wellington Keri  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.6, 2005-01, pp. : 859-878

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts

By Reusser Pierre  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1745-1753

Informa Healthcare

Access to resources Recommend Favorite

Raltegravir: A Review of its Use in the Management of HIV Infection in Treatment-Experienced Patients

By Croxtall Jamie D.   Keam Susan J.  

Drugs, Vol. 69, Iss. 8, 2009-06 ,pp. : 1059-1075

Adis International

Access to resources Recommend Favorite

Valganciclovir prevents CMV infection in lung transplantation

By  

Inpharma, Vol. 1, Iss. 1465, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Valganciclovir proves its value in CMV prevention

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 608, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Emtricitabine: A Review of its Use in the Management of HIV Infection

By Frampton James E.   Perry Caroline M.  

Drugs, Vol. 65, Iss. 10, 2005-01 ,pp. : 1427-1448

Adis International

Access to resources Recommend Favorite